Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00557388
Collaborator
National Nutrition and Food Technology Institute (Other)
120
1
10
35
3.4

Study Details

Study Description

Brief Summary

Aging is associated with the loss of lean muscle mass, termed sarcopenia. Food intake and in particular the ingestion of protein or amino acids has been shown to be a powerful stimulus to promote net muscle protein anabolism. However this anabolic response following a meal-like protein bolus seems to be blunted in the elderly as compared to young adults.

The first aim of this proposal is to investigate the post-prandial muscle protein synthesis rates in young and elderly men in response to a meal-like protein bolus after a period of rest or physical activity (study A). The rest trial (REST) will act as a proof-of-principle study to examine the blunted protein synthetic response in the elderly, and as a control trial in comparison with the exercise trial (EXC) to establish the surplus value of physical activity prior to protein intake on muscle protein synthesis.

The second aim of this proposal is to determine the surplus value of an increased quantity of the ingested protein bolus (study B). Large amounts of protein (40 and 60 g) will be compared to a meal-like amount of protein (20 g) as a means to maximize plasma amino acid availability and/or to stimulate muscle protein anabolism.

The third aim of this proposal is to study the differences in quality of the ingested protein bolus (study C). Instead of significantly increasing the quantity of the protein bolus, we will also apply a more practical approach to augment skeletal muscle protein synthesis rates; modifying the digestibility or amino acid composition of a meal-like protein bolus.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Protein/Amino Acids
  • Other: Physical exercise
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly
Study Start Date :
Dec 1, 2007
Actual Primary Completion Date :
Nov 1, 2010
Actual Study Completion Date :
Nov 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Young men 18-30 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Other: Physical exercise
The physical exercise protocol will consist of low intensity cycling and light resistance-type exercise; after 5 minutes of self-paced cycling, subjects will perform 6 sets of 10 repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The Netherlands) and 6 sets of 10 repetitions on the leg extension machine (Technogym BV, Rotterdam, The Netherlands). The first 2 sets of both resistance exercises will be performed at 40% of the subjects' 1RM. Sets 3-4, and 5-6 will be performed at 55% and 75% of 1RM, respectively, with 2 minutes rest intervals between sets.

Experimental: 2

Young men 18-30 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 3

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Other: Physical exercise
The physical exercise protocol will consist of low intensity cycling and light resistance-type exercise; after 5 minutes of self-paced cycling, subjects will perform 6 sets of 10 repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The Netherlands) and 6 sets of 10 repetitions on the leg extension machine (Technogym BV, Rotterdam, The Netherlands). The first 2 sets of both resistance exercises will be performed at 40% of the subjects' 1RM. Sets 3-4, and 5-6 will be performed at 55% and 75% of 1RM, respectively, with 2 minutes rest intervals between sets.

Experimental: 4

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 5

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 6

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 7

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 8

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 9

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Experimental: 10

Old men 70-85 years, BMI < 27 kg/m2

Dietary Supplement: Protein/Amino Acids
Casein Whey Leucine

Outcome Measures

Primary Outcome Measures

  1. All interventions will affect muscle protein synthesis. With the application of amino acid tracer methodology we are able to determine muscle protein synthesis. [6 hours]

Secondary Outcome Measures

  1. Differences in rate of uptake/absorption from the intestine. [6 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • In study A, non-obese male subjects (BMI <27) between the age of 18-30 yrs and 70-85 yrs will be selected.

  • In studies B and C, non-obese male subjects (BMI <27) between the age of 70-85 yrs will be selected.

Exclusion Criteria:
  • Type II diabetes or other known diseases

  • Use of medication

  • Female

  • Other ages or BMI than indicated above

  • Participation in any regular exercise program.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Maastricht Maastricht Limburg Netherlands 6200 MD

Sponsors and Collaborators

  • Maastricht University Medical Center
  • National Nutrition and Food Technology Institute

Investigators

  • Principal Investigator: Luc van Loon, Phd, Maastricht University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00557388
Other Study ID Numbers:
  • MEC 07-3-086
  • TIFN A-1002
First Posted:
Nov 14, 2007
Last Update Posted:
Sep 14, 2011
Last Verified:
Sep 1, 2011
Keywords provided by Maastricht University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2011